Depression Can Be Treated With Anti-Inflammatory Drugs- A Medical Breakthrough
Depression has become too common among the middle-aged as well as the adolescent people.
In 2015, a projected 3 million adolescents who were aged between 12 to 17 in the United States had no less than one major depressive period. This number denoted approx. 12.5% of the total adolescent U.S. population aged between 12 to 17.
Isn’t The Fact Shocking?
The same horrifying results are found with the middle-aged and older people. Even, depression is the major reason for suicide throughout the world at present.
But recently a study has shown some optimistic result with the anti-inflammatory drugs.
Yes, you read it right. The anti-inflammatory drugs can cure depression.
Presently anti-inflammatory drugs are used to treat some autoimmune diseases like psoriasis and rheumatoid arthritis. But a recent study published in the journal Molecular Psychiatry says that this anti-inflammatory drugs can reduce depression symptoms.
In the research trial, ‘anti-cytokine drugs’ were used to treat several autoimmune inflammatory diseases. While the scientists were looking for the other beneficial aspects of the drugs, they found that there was a noteworthy positive result against depression in these drugs.
How It Works
Whenever we are affected by some ailments like a stomach bug or even influenza, our immune system sends immune cells to the place to fight back that infection. While sending blood, the immune system sends a protein called Cytokines along with blood, and this entire process is known as systemic inflammation.
Also Read: Dirt Not Always Bad, It Can Be Good Too
However, these anti-inflammatory drugs are not the typical drugs that we take for inflammation, like ibuprofen, but this is a particular new class of anti-inflammatory drug.
This study may come out as a breakthrough in the medical research as this may help the several depression patients on whom the antidepressant drugs do not work. Currently, depression patients are treated with drugs that are targeted to specific neurotransmitters. But these drugs do not work for almost one-third of the patients. This research can bring out the personalized medicines for treating depression.
Source: Cambridge News